Related Experiment Video
Updated: May 28, 2026
07:32
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Targeting Eph receptors with peptides and small molecules: progress and challenges
Roberta Noberini1, Ilaria Lamberto, Elena B Pasquale
1Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
Seminars in Cell & Developmental Biology
|November 3, 2011
Summary
Eph receptors, a family of receptor tyrosine kinases, are crucial in cell signaling. Researchers are developing small molecules to target these receptors for therapeutic applications, like cancer treatment.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Eph receptors are receptor tyrosine kinases that mediate bidirectional cell signaling with their ephrin ligands.
- This signaling is critical for various biological processes, including development and tissue repair.
- Dysregulation of Eph/ephrin signaling is implicated in diseases like cancer.
Purpose of the Study:
- To review the potential of targeting Eph receptors and ephrin ligands for therapeutic interventions.
- To highlight the challenges and strategies in developing small molecules and peptides that modulate Eph receptor activity.
- To explore the use of these molecules as research tools and drug delivery agents.
Main Methods:
- Identification and characterization of small molecules and peptides targeting Eph receptors.
- Analysis of binding affinities and inhibitory effects on Eph receptor-ephrin interactions and kinase activity.
- Evaluation of lead-like properties for drug development.
Main Results:
- Several peptides and small molecules have been identified that inhibit Eph receptor-ephrin binding or kinase activity.
- These molecules demonstrate potential as research probes and therapeutic leads.
- Challenges remain in achieving high affinity and selectivity for Eph receptor targeting.
Conclusions:
- Targeting Eph receptors and ephrin ligands offers promising therapeutic avenues, particularly in oncology.
- Development of selective inhibitors with favorable drug-like properties is crucial.
- Further strategies involving additional binding sites and ephrin ligands warrant exploration.
Related Concept Videos
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...